Longevity in the News: Coenzyme Q10 shown to reverse memory deficits

January 1, 1970

New antibody reduces amyloid plaques associated with Alzheimer’s disease

A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer’s disease, signaling its promise as a potential treatment for the disease, according to a team of researchers at UTHealth Houston.


Stem cells could be key to slowing aging process

A team of researchers at the University of Auckland, New Zealand found that women’s stem cells are more potent than men’s, which may explain why women live longer.


Coenzyme Q10 shown to reverse memory deficits

Q10 reverses aging-induced memory impairment. Reduces ATP production, decrease in mitophagy-related proteins (PINK, Parkin, and P62 levels and LC3II/I ratio), excessive generation of reactive oxygen species and lipid peroxidation, and apoptosis in the hippocampus. 


Detecting infections faster with CRISPR-Cas

Wageningen University & Research (WUR) has received a grant of 150,000 euros from the European Research Council (ERC), together with spinoff Scope Biosciences, to further research and enhance their diagnostic technology ScopeDx.


Pretzel Therapeutics launches with $72.5m Series A to pioneer mitochondrial therapies for longevity

Pretzel Therapeutics, a biotech company focused on harnessing the intricacies of mitochondrial biology to develop groundbreaking therapies, launched yesterday with a $72.5 million Series A financing.


Scientists find a drug that may reduce muscle aging

Scientists have found that a well-known drug can delay the progression of age-related muscle weakness by suppressing mTORC1.